Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Feb 06, 2017 7:00 AM - Feb 08, 2017 5:00 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Regulatory Submissions, Information, and Document Management Forum

Session 2 Track 1: Business Impacts to IDMP

Session Chair(s)

Vada A. Perkins, DrSc, MSc

Vada A. Perkins, DrSc, MSc

Vice President, Global Head of Regulatory Intelligence & Policy

Boehringer Ingelheim, United States

Explore some of the opportunities and challenges of addressing IDMP integration within the pharmaceutical environment. Discussion topics include collaborative processes and principles for successful assessment and implementation of an IDMP program, along with a case-study from a company perspective to provide lessons learned in their approach to IDMP to deliver business improvements.

Learning Objective : Ability to identify and ultimately plan for a synergistic IDMP/RIM program. Plan for and perform analysis on various processes in order to formulate an action plan for long term compliance. Describe and share with colleagues the long term goal of IDMP, how it's not just about data, as well has how other agency activities come into play.

Speaker(s)

Sue  Metz

Collaborative Processes for a Successful IDMP Program

Sue Metz

IRISS Forum, United States

President/CEO

Thomas  Hornbaek Svendsen, MS

IDMP Readiness – Status Based on Pharmaceutical Company Assessments in Europe

Thomas Hornbaek Svendsen, MS

NNIT A/S, Denmark

Managing Consultant

Christian A. Buckley, MBA, RAC

Sponsor Perspective Case Study

Christian A. Buckley, MBA, RAC

Astellas, United States

Associate Director, Regulatory Affairs

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.